8:32 am ARCA biopharma announces IDE submission to FDA for Gencaro companion diagnostic test; phase 2B/3 GENETIC-AF trial on track to begin patient enrollment in Q1 2014

8:32 am ARCA biopharma announces IDE submission to FDA for Gencaro companion diagnostic test; phase 2B/3 GENETIC-AF trial on track to begin patient enrollment in Q1 2014

more

View todays social media effects on ABIO

View the latest stocks trending across Twitter. Click to view dashboard

Share this post